CLS Investments »

Aquestive Therapeutics shares owned by CLS Investments

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by CLS Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $54k 13k 4.15

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Ishares Tr Core S&p500 Etf (IVV)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation Call Option (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Total (IXUS)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)

View all positions for CLS Investments

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Federated Investors
Balyasny Asset Management
Samsara BioCapital
State Street Corporation
Geode Capital Management
Bank of America Corporation
Morgan Stanley
Susquehanna International
Two Sigma Investments
Jane Street
Janney Montgomery Scott

View all funds holding Aquestive Therapeutics